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ABSTRACT
The recognition of DF (DHF Dengue Hemorrhagic Fever) is very complicated due to occurrence of 
a wide spectrum of clinical signs and symptoms during acute phase of illness. Moreover, presence of 
four serotypes further complicates the prognosis. To investigate the predictors of disease severity and 
elucidate the prognostic markers among four dengue serotypes, this study was conducted on 320 
inpatients having acute febrile illness clinically suspected as DI, over a period of fi ve years. Dengue 
serotypes were confi rmed by multiplex reverse transcriptase (RT)-PCR. Eighty patients were positive 
for DI with presence of Den-1, Den-2, Den-3, and Den-4 in 8, 35, 27 and 10 patients, respectively. 
The severe clinical manifestations, abdominal pain and hepatomegaly, were comparatively higher in 
Den-2 patients. Liver aminotransferases levels were also higher in Den-2 patients (app. 5 fold). This 
study clearly indicates the hyperendemicity of all dengue serotypes. Nucleotide sequencing of En-
velope region revealed that the presently emerged Den-3 belongs to type III, having high homology 
with genotype responsible for number of outbreaks in 1980s. The re-emergence of this deadly type 
can be suspected to cause more outbreaks in future and is a matter of great concern.
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[Braz J Infect Dis 2010;14(2):141-146]©Elsevier Editora Ltda.
INTRODUCTION 
Dengue virus, a member of the family ﬂ aviviri-
dae, has four serologically related but genetically 
distinct virus serotypes, namely, Den-1, Den-2, 
Den-3 and Den-4. Dengue infection (DI) is 
presently the most important arboviral disease 
of mankind.1 DI may either remain asympto-
matic, or rise as mild infection called dengue 
fever (DF). In some instances, it results into 
dengue hemorrhagic fever (DHF).2,3 At present, 
DI is endemic in over 100 countries worldwide 
and causes nearly 100 million cases of DF, 
500,000 cases of DHF and 24,000 deaths each 
year.4-7 Pathophysiological basis of hemorrhage 
in dengue patients still remains poorly under-
stood.6 A patient having DI can rapidly develop 
life-threatening hemorrhagic form, as early 
as 2 days after the onset of illness.1,8-10 Dengue 
outbreaks in India are now following the pat-
tern like other high burdened countries (e.g., 
Thailand and Indonesia).11 The study during 
the last major DHF outbreak in 1996 reported 
Den-2 as the predominant serotype circulating 
in India.12 However, the extensive research dur-
ing this study, since 2002, highlights the pres-
ence of all four serotypes, with predominance 
of Den-2 and Den-3 serotypes.13 
Because all four dengue virus serotypes 
cause a number of illness, defi ning precisely 
which clinical manifestations and laboratory 
abnormalities are associated with different se-
rotypes remains disappointing.14 Conducted to 
evaluate disease treatment, the current study, a 
fi rst of its kind from this geographical region, 
was planned to recognize the clinical and bio-
chemical manifestations occurring during acute 
stage of infection in patients infected with vari-
ous serotypes. The present work presents a bet-
ter understanding of correlation between sero-
types and disease manifestations during acute 
phase. Further, genotypic characterization of 
Den-3, the second most predominant serotype 
during this study, revealed the threat associated 
with this newly re-emerged serotype.
METHODOLOGY 
Patient selection and sample processing 
Blood samples were collected within 5 days of 
fever onset (acute phase), from 320 patients 
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clinically suspected of DI, attending the outpatient and 
medical wards of Lok Nayak Hospital, a tertiary care hos-
pital at Delhi, India, from January 2002 to November 2006. 
On the basis of WHO inclusion criteria,1 a patient having an 
acute febrile illness of 2-7 days duration with two or more of 
the following manifestations: severe head ache, retro-orbital 
pain, myalgia, arthralgia, rash, hemorrhagic manifestations, 
and/or leucopenia was categorized as having DF. Patient 
with DHF is a probable case of DF, having hemorrhagic ten-
dency along with thrombocytopenia (platelets 100,000/cu. 
mm or less) and evidence of plasma leakage. Fifty normal 
healthy age and sex matched individuals, having no history 
of febrile or other illness in the last three months were in-
cluded as negative controls. 
The prior approval has been granted by the Ethical Com-
mittee of the Institute to conduct this study. Informed con-
sent was obtained from all patients. A case was excluded if 
routine laboratory testing suggested bacterial infection or 
any viral infection other than DI or any other disease. 
Detection of dengue serotypes by multiplex 
RT-PCR
Reference strains specifi c for serotype Den-1: Hawaii; Den-2: 
P-23085; Den-3: 633798; and Den-4: 642069 (obtained from 
National Institute of Virology, Pune, India) were individu-
ally inoculated in C6/36 cells containing Leibovitz-15 media 
with 2% Fetal Bovine Serum.15-17 After 7 days, supernatant 
was separated from each culture vial at 1500 rpm for 10 
minutes, 4° C and stored at -70° C, to be used as positive 
controls. The presence of dengue serotypes was confi rmed 
by multiplex RT-PCR, using four serotype specifi c primers 
pairs described earlier.13,18 Serum samples from all patients 
were similarly processed for detection of dengue serotypes. 
Ampliﬁ cation of E-NS1 gene region by RT-PCR 
As per the method of Domingo et al.,19 5 µl of dengue vi-
ral RNA was used for RT-PCR mix to amplify E-NS1 gene 
region of Den-3 serotype specifi c strains. The reaction was 
carried out in two steps and the fi rst step consisted of RT-
PCR using outer sense primer S1871DEN3 and anti-sense 
primer AS2622DEN3 specifi c for Den-3. This reaction 
was followed by nested PCR using internal sense primer; 
S2176DEN3 specifi c for Den-3 and a common anti-sense 
primer AS2504DEN. 
Nucleotide sequencing of E-NS1 region of Den-3 
and phylogenetic analysis 
The purifi ed DNA products (25-50 ng) were sequenced by 
ABI 3130xl automated DNA sequencer (Applied Biosystems, 
USA) using dideoxy chain termination method with ABI 
sequencing kit following manufacturer’s instructions, us-
ing primers S2176DEN3 and AS2504DEN. Sequences thus 
generated were submitted to Gene Bank database. Sequence 
identity matrices and multi-sequence alignments from 
DNA databases were generated using Basic Local Alignment 
Search Tool; available at NCBI website (http://www.ncbi.
nlm.nih.gov/BLAST) and ClustalW programme (http://
align.genome.jp/). 
Hematological and biochemical investigations 
Blood samples were collected into an EDTA-coated Vacu-
tainer tube (Becton Dickinson Vacutainer Systems, Franklin 
Lakes, N.J.), for hematological investigations and plain Va-
cutainer tube (Becton Dickinson Vacutainer Systems, Fran-
klin Lakes, N.J.), for biochemical investigations. All the tests 
were performed as per standard laboratory procedures. 
Statistical analysis 
Statistical analysis was performed with Epi Info version 3.3.2 
(updated 2005, Center for Disease Control and Prevention, 
USA). Proportions of patients with abnormal clinical, hema-
tological and biochemical fi ndings between the two groups 
were compared using Chi (χ2)/Fischer exact test. Mean 
values between four serotype groups were compared using 
analysis of variance (ANOVA). Kruskal-Wallis test was ap-
plied, when variance in samples was high. Odds ratio (OR) 
for disease outcomes in serotypes was calculated to assess 
strength of association at 95% confi dence intervals. The re-
sults were considered statistically signifi cant when error was 
less than 5% (p < 0.05). 
RESULTS
Distribution pattern of dengue serotypes among 
dengue patients 
On the basis of multiplex RT-PCR, DI was confi rmed in 
eighty patients. Serotypic characterization identifi ed 35 pa-
tients being positive for Den-2, 27 for Den-3, 10 for Den-4, 
and 8 patients positive for Den-1. Thus, Den-2 was detected 
in most patients, followed by Den-3. 
Correlation of dengue serotypes with clinical and hem-
orrhagic manifestations 
Among the wide spectrum of mild and severe clinical 
and hemorrhagic manifestations analyzed, the incidence 
of only two severe manifestations, namely, abdominal pain 
(p < 0.05) and hepatomegaly (p < 0.05), was signifi cantly 
different between four serotype groups. While frequency 
of clinical manifestations was most predominant in Den-2 
infected cases, severe hemorrhagic manifestations were pre-
dominant in Den-4 infected group. Individual analysis of 
each serotype group demonstrated hepatomegaly to be sig-
nifi cantly higher in Den-2 as well as Den-3 infected patients. 
Abdominal pain was signifi cantly higher in Den-2 group 
and anorexia was signifi cantly higher in Den-3 group only. 
The overall bleeding frequency was also signifi cantly differ-
ent between the four serotype groups (p < 0.01). However, 
no signifi cant difference was observed on analysis of each 
bleeding manifestation individually (Table 1). 
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Correlation of serotypes with hematological 
parameters 
Thrombocytopenia was the common hematological 
manifestation during acute phase. The lowest mean plate-
let counts were observed in the Den-2 infected patient 
group. Hematological parameters (except TLC) showed 
significant difference in disease group when compared 
with control group (Table 2). However, none of the pa-
rameters showed significant difference within the disease 
groups. In Den-3 infected patients, a strong correlation 
was found between hematocrit and hemoglobin levels (p 
value < 0.05, r = 0.411) and also platelet counts and TLC 
levels (p value < 0.05, r = 0.484). In patients infected with 
Den-2, correlation was observed between platelet counts 
and hemoglobin levels (p value < 0.05, r = 0.25). How-
ever, there was no correlation between any of the hemato-
logical parameters in Den-1 and Den-4 infected patients 
in the present study.
Table 1. Correlation of Dengue serotypes with clinical and hemorrhagic manifestations
Disease Manifestations               Dengue serotype groups     
 Den-1 Den-2  Den-3  Den-4 p Value
Abd Pain, n (%)  3 (50)  25 (71.4)  9 (33.3)  7 (70) < 0.001
Hepatomegaly, n (%) 1 (12.5) 17 (49)  5 (18.5)  2 (20)  < 0.05
ROP, n (%)  4 (50)  23 (65.7)  13 (48.2)  6 (60)  0.54
Anorexia, n (%)  7 (87.5)  33 (94.3)  19 (70.4)  8 (80)  0.18 
Arthalgia, n (%)  5 (40)  24 (68.5)  16 (59.3)  4 (40)  0.54 
Myalgia, n (%)  4 (50)  21(60)  14 (51.9)  6 (60)  0.95 
Bleeding  4 (50)  31 (88.6)  12 (44.4)  10 (100) 0.001
Malena 3 (37)  11 (31.4) 4 (14.8) 4 (40) 0.3
Hemetamesis 1 (12.5) 9 (25.7) 2 (7.4)  3 (30) 0.22
Epistaxis 0 (0) 12 (34.3) 3 (11.1) 4 (40)  0.07 
Footnote: Significant p values are underlined (calculated by Chi square Test/Fisher’s Exact Test)
Abd = abdominal; ROP = retro-orbital pain.
n = number of patients having manifestations.
Table 2. Correlation of the four dengue serotypes with hematological parameters 
Hematological Parameters  Control Group Den-1 Den-2 Den- 3 Den-4 p value
Hb 12.5  12.5 11.6 12.2 10.6 
< 0.05
(mmHg) (±0.8) (±1.04) (±3.0) (±1.3) (±2.6)
TLC 6930  5900 6608 6559  6610
(cells/mm3) (±1221)  (±2389) (±2037)  (±3467) (±1737) 
0.6
Hematocrit 43.3 38.12 (%) 37.25 39.6 37.3
 (±3.8) (±3.4) (±5.9) (±3.6)  (±9.1) 
< 0.05
Platelet count 312619 72000 66700 72900 75400
(cells/mm3) (±66150) (± 55500)  (±40600) (±42000) (±39900)   < 0.01
PT 14.4 14.5 16  17.2 16.6 
(sec) (±0.7) (±0.7) (±1.1) (±2.2) (±1.8) 
< 0.001
Hb = hemoglobin; TLC = total leukocyte count.
Significant p values are given in underlined (calculated by comparing the four serotype groups with control group – calculated 
by ANOVA test/Kruskal Wallis test). 
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Correlation of serotypes with biochemical proﬁ le 
The elevation of liver aminotransferase levels was maxi-
mum in Den-2 patients. Increase of about fi ve-fold in levels 
of both the aminotransferase was noticed as compared to 
healthy controls. The mean level of serum albumin in Den-2 
infected patients was slightly reduced, as compared to the 
normal reference limits. However, when compared with 
normal healthy controls, the mean levels of all biochemi-
cal parameters were signifi cantly altered (Table 3). Like he-
matological parameters, there was no signifi cant different 
between biochemical parameters within serotype groups. 
The frequency of patients with elevated levels of SGOT was 
signifi cantly higher in Den-2 group (p < 0.05) showing a 
strong association (O.R. 2.42; CI = 0.89-6.64). 
Genotypic characterization of Den-3
There was 99-100% nucleotide homology between the se-
quences of fi ve Den-3 strains isolated from dengue pa-
tients (Accession numbers: EF094024, EF119833, EF119834, 
EF119835, EF119836). AT composition of the sequences from 
the present study was between 51-58.3%. Comparison of E-
NS1 region of these strains with published sequences of other 
strains of Den-3 categorized then into subtype III (Table 4). 
DISCUSSION 
DI has now become a regular post-monsoon phenomenon 
in most parts of India.13,20 Most of Indian studies on clini-
cal and laboratory profi le of dengue patients have involved 
serologically positive patients. Because serological diagnosis 
demands a collection of samples fi ve days post disease on-
set, it thus depicts the pattern of manifestations occurring in 
the convalescent phase of disease. As severe complications 
related to DHF may occur very early in disease, it is impor-
tant to explore prognostic markers of severe disease during 
acute phase. The hyperendemicity with co-circulation of 
two or more serotypes during the same time period have 
been widely suspected as one of the major cause of disease 
severity in South East Asia.8,21 Various studies are trying to 
establish connection between causative serotype and disease 
outcome. Few of which propose that Den-2 and Den-3 may 
cause more severe disease,8,22-24 however, a defi nite link be-
tween distinct serotypes and severe manifestations has not 
been established yet. 
This study provided direct evidence for the presence of 
all four serotypes in this geographical region, with Den-2 
and Den-3 as two predominant serotypes. The clinical man-
ifestations, such as abdominal pain and hepatomegaly, were 
Table 3. Serum levels of biochemical parameters: Comparison between four serotypes and healthy controls 
Variables¥ (units) Den-1  Den-2  Den-3  Den-4 p value
AST  30.9 105.7 79.31 62.3 < 0.001
(IU/L) (± 11.4) (± 138.3)  (±97.3)  (± 64.6) 
ALT  19.4 65.8 48.53 39.6 
(IU/L)  (±6.2)  (±90.67) (±60.8) (±33.4) < 0.001
T. Protein (g/L) 6.3  6.3 6.03 6.2
 (± 0.62) (±0.92) (±1.1) (±0.94) < 0.001
Albumin (g/L) 3.5  3.4 3.5 3.5
 (±0.32) (±0.5) (±0.55) (±0.53) < 0.001
¥ = Value of each parameter is expressed as mean value ± S.D. Significant p values are underlined (calculated by comparing the 
four serotype groups with control group - calculated by ANOVA test/Kruskal Wallis test).
Table 4. Den-3 strains: analysis of E-NS1 gene region 
Strain Year of isolation Serotype (Genotype)  Gene bank accession 
   number 
ARG051 2003 Den-3 (III) EF094024
106ARMG1 2005 Den-3 (III) EF119833
206ARMG1 2005 Den-3 (III) EF119834
306ARMG1 2006 Den-3 (III) EF119835
406ARMG1 2002 Den-3 (III) EF119836
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higher in Den-2 patients, indicating a role in causing liver 
function abnormalities. Incidences of severe hemorrhagic 
manifestations, such as epistaxis, malena, and hemetemesis, 
were higher in patients having Den-4. As Den-4 positivity 
remained very low, there is a need of more studies to validate 
this fi nding. In a retrospective study from Thailand, Den-2 
has been documented as the most frequent serotype among 
DHF cases (35%), followed by Den-3 (31%).24 In a study in 
Thailand,23 Den-2 showed association with a greater pleural 
effusion index and with a higher percentage of DHF cases. 
In congruence with the present study, Corwin et al.25 also 
found that Den-1 is associated with less severe disease. Sev-
eral reports from other countries articulating differences in 
disease severity associated with distinct dengue serotypes 
support our results. It is suggested that screening for abdom-
inal pain, and hepatomegaly along with severe hemorrhagic 
manifestations in patients tested positive by multiplex RT-
PCR during acute phase of illness would be an asset in better 
prognosis. Hepatic dysfunction is common in patients with 
severe dengue manifestations.26 Liver dysfunction might be 
responsible for the decreased synthesis of specifi c factors of 
the intrinsic pathway, an unbalance of which may conse-
quently cause hemorrhage.26 In our fi nding, mean values of 
both the transaminases were signifi cantly raised in all four 
serotype groups, when compared with control groups. El-
evation of liver aminotransferase levels was maximum in 
Den-2 patients (app. fi ve-fold increase). Moreover, reduc-
tion in serum albumin levels points towards risk of pleural 
effusion. Higher levels of SGOT and SGPT have been earlier 
reported from a limited sample of Den-2 infected patients.27 
However, more investigations are still required before a defi -
nite association of any serotype with hematological or bio-
chemical profi les can be ascertained. As mortality is usually 
linked to delayed provision of supportive treatment, a better 
understanding of clinical and biochemical profi le during the 
acute phase of illness is extremely important. 
Changes in the envelope protein in particular are sug-
gested to alter host cell susceptibility, thereby affecting virus 
replication and disease severity.28 The nucleotide sequence 
comparison of E-NS1 region of fi ve Den-3 strains from 
present study with published sequences using BLAST re-
vealed that irrespective of the year in which samples were 
collected, all of them belonged to genotype III. The strains 
isolated in our study showed ~98% homology with subtype-
III of Den-3 strains isolated during epidemics in 1984 from 
India, in 1985 from Mozambique, in 1989, 1991 and 2000 
from Sri Lanka, and in 2000 from Martinique.28,29 The iden-
tifi cation of Den-3 during the outbreak in India during 2003 
and its continued presence in later years indicates its resur-
gence in a dominant form and, thus, a matter of great con-
cern. Constant and thorough epidemiological surveillance 
is mandatory to control the invasion and spread of dengue 
viruses. Studies of these types would defi nitely be an asset in 
the establishment of in time effective control strategies.
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